Core Alternative Capital Vertex Pharmaceuticals Inc Transaction History
Core Alternative Capital
- $448 Million
- Q4 2024
A detailed history of Core Alternative Capital transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Core Alternative Capital holds 131 shares of VRTX stock, worth $59,369. This represents 0.01% of its overall portfolio holdings.
Number of Shares
131
Previous 131
-0.0%
Holding current value
$59,369
Previous $60,000
13.33%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding VRTX
# of Institutions
1,728Shares Held
223MCall Options Held
1.65MPut Options Held
1.38M-
Capital World Investors Los Angeles, CA28.3MShares$12.8 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$10.5 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.66 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.36 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$4.73 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $116B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...